<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00387803</url>
  </required_header>
  <id_info>
    <org_study_id>Clinicals0010</org_study_id>
    <nct_id>NCT00387803</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation</brief_title>
  <official_title>VENTAK CHF/CONTAK CD Biventricular Pacing Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of this study was to determine if cardiac resynchronization therapy when combined
      with defibrillation is safe and effective in the treatment of symptomatic heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients enrolled received a device with cardiac resynchronization therapy (CRT) and
      defibrillation. Patients were randomized to CRT on or off for up to six months and evaluated
      for mortality, hospitalization, and functional outcomes including exercise capacity, quality
      of life, symptomatic status, and echocardiographic analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 1998</start_date>
  <completion_date>August 2001</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of all-cause mortality, heart failure hospitalization, and ventricular tachyarrhythmia</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak VO2</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA Class</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six minute walk distance</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic measures</measure>
  </secondary_outcome>
  <enrollment>581</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <condition>Ventricular Fibrillation</condition>
  <condition>Tachycardia, Ventricular</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac Resynchronization Therapy with Defibrillation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic heart failure

          -  Left ventricular ejection fraction &lt;= 35%

          -  QRS width &gt;= 120 ms

          -  Indicated for an implantable cardioverter defibrillator

        Exclusion Criteria:

          -  Indicated for a pacemaker

          -  Atrial tachyarrhythmias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Steven Higgins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leslie A Saxon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California San Francisco Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Boehmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Teresa De Marco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California San Francisco Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Multiple locations</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003 Oct 15;42(8):1454-9.</citation>
    <PMID>14563591</PMID>
  </results_reference>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2006</study_first_submitted>
  <study_first_submitted_qc>October 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2006</study_first_posted>
  <last_update_submitted>January 23, 2007</last_update_submitted>
  <last_update_submitted_qc>January 23, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

